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Background: Although infection with Hepatitis B Virus (HBV) remains a global public health problem, little is
known about its epidemiology in pregnancy in sub-Saharan Africa. This study sought to determine the prevalence
of, and identify factors associated with hepatitis B surface antigen (HBsAg) positivity among pregnant women in the
Buea Health District (BHD) in rural Cameroon. We also assessed pregnant women’s knowledge about hepatitis B.
Methods: A cross-sectional, descriptive study was undertaken. Participants were evaluated using a structured
questionnaire with clinical examination and were then screened for HBsAg using a commercial rapid diagnostic test.
Assessment of knowledge was done using a hepatitis B basic knowledge summary score.
Results: Of the 176 pregnant women studied, 9.7% (95% CI: 5.7%, 15%) tested positive for HBsAg. None of the risk
factors assessed was significantly associated with HBsAg positivity. The hepatitis B knowledge summary score
ranged from 0 to 12 with a mean of 1.5 (SD = 3.14, median = 0, IQR = 0 to 0). Only 16% of participants had scores
greater than 6/12. The knowledge summary score of the participants was associated with the educational level
(p-value = 0.0037).
Conclusion: The high prevalence of HBsAg (9.7%) among women of child bearing age suggests that vertical
transmission of HBV may be a public health problem in Buea Health District. Knowledge of HBV among pregnant
women was poor. We recommend that all pregnant women ought to be routinely screened for HBV and that
health education on HBV should be provided to pregnant women especially during antenatal visits.
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Infection with the hepatitis B virus (HBV) occurs world-
wide and constitutes a major public health problem [1].
Over 380 million people worldwide are chronic carriers
of HBV and more than 2 million deaths occur annually
from HBV related diseases [2]. Approximately 65 million
of all chronically infected individuals live in Africa [3,4].
In Cameroon, recent studies reported HBV prevalence
rates as high as 10.1% and 12.1% among blood donors in
hospital blood banks [5,6]. The prevalence of HBsAg in
pregnancy does not vary much from that in the general
population [7]. In Cameroon, studies carried out by
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reproduction in any medium, provided the orrevealed that the prevalence of hepatitis B surface antigen
was greater than 8% [8,9]. Two more recent studies in
Yaounde, Cameroon, estimated the prevalence of HBsAg
in pregnancy at 7.9% (in 2005) and 7.7% (in 2013) [10,11].
Little is known on the prevalence of hepatitis in pregnancy
in non-urban areas.
The risk factors for hepatitis B infection are known to
be linked to body fluids especially those with high concen-
tration of the virus like blood, semen and vaginal secre-
tions [12]. Traditional practices that expose people to
hepatitis B infection like scarification, ear and nose pier-
cing as well as tattoos have led to higher prevalence in cer-
tain zones but not necessarily in pregnancy [13]. The risk
factors for hepatitis B infection during pregnancy vary
among communities depending on the cultural practices
and some traditional beliefs. In one study carried out in al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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fied were higher mean parity, higher number of sexual
partners since sexual debut, polygamy and previous sexu-
ally transmitted infection [14]. In addition to determining
prevalence, risk factors for HBV infection need to be iden-
tified in each setting in order to potentially design targeted
preventive measures.
Hepatitis B virus (HBV) infection may go undetected.
Unawareness of an ongoing infection delays the diagno-
sis of HBV-related liver disease and favors the spread of
the virus [15]. In a study to assess awareness of HBV in-
fection among patients in a clinic in Italy, it was noticed
that up to 40.3% of the participants were not aware
of their infection [16]. Studies to assess the knowledge
of hepatitis B are more often conducted with health
personnel being participants. Pregnant women too are a
vulnerable group and theirs is the risk of transmitting
the infection to the newborn if the mother is infectious.
It is for these reasons that this study was designed to de-
termine the prevalence of HBsAg among pregnant
women in the BHD and to identify the risk factors asso-
ciated with hepatitis B in pregnancy. The knowledge of
participants about hepatitis B was also assessed in this
study.
Methods
This cross-sectional, descriptive study was carried out in
antenatal clinics (ANC) in the Buea Health District of
Cameroon from the June to July 2012. The ANCs in-
volved were those of the Buea Regional Hospital, Buea
Road Health Center, Buea Town Health Center, Muea
Subdivisional Hospital, Mile 16 Health Center and Soli-
darity clinic. There are other health centers found in the
health district, but because of their low number of preg-
nant women per ANC session (<4 per week) and the ir-
regularity of their ANC sessions, they were not included
in our study setting. Our study and target population
was made up of pregnant women who attend ANC in
the health district. The sampling method was consecu-
tive. All pregnant women attending ANC in the health
district were eligible for participation and were included
if they agreed to participate. All participants who con-
sented were interviewed using a standard questionnaire
adapted from the WHO protocol for assessment of
hepatitis B infection in antenatal patients [17]. Prior to
use in the study participants the questionnaire was pilot
tested in 16 pregnant women in our setting with the aim
of revising poorly structured questions, estimate the
average time required to fill the questionnaire and thus
validate the use of the questionnaire in our context.
After the examination of the participant, 3 mls of fresh
venous blood was collected by venipuncture into an
EDTA tube. The plasma of collected samples was tested
for presence of HBsAg using a commercial hepatitis Bsurface antigen test strip, the DiaSpot One Step Hepa-
titis B test (DiaSpot Rapid Diagnosis, Jakarta, Indonesia).
This required the deposition of two drops of the plasma
sample onto the corresponding receiving section of the
strip and waiting a minimum of five minutes before
reading the test result. The test result is said to be posi-
tive when two bands appear; one in the test region and
another in the control region. The test result was
marked negative when one band appears in the control
region and no band appears in the test region. In situa-
tions where the control region had no test band, the test
was marked invalid. For invalid cases, the used strip is
discarded. A new strip is gotten and the remaining blood
in the EDTA test tube was used to obtain another identi-
cal sample. This was again tested in a similar manner
and the result obtained recorded accordingly.
Statistical analysis
The analysis of the data was done using EPI-INFO Version
3.5.1 and MICROSOFT EXCEL-2007. The prevalence of
HBsAg among the participants was the ratio between
HBsAg positive samples and the total samples collected.
For every potential risk factor assessed (history of surgery,
history of blood transfusion, abortion, scarification, pier-
cing, tattoos, condom use, sex partners and history of
sexually transmitted infection), the risk ratio of antigen
positivity comparing those with potential risk factor to
those without the risk factor was determined. The statis-
tical significance of the association between each potential
risk factor and antigen positivity was assessed using a
Fisher’s exact test. Risk factors with p-values < 0.05 were
to be considered significant and associated. The know-
ledge of hepatitis B was assessed by determining how
many participants had correct responses to the questions
on knowledge of hepatitis B. Each knowledge question
was scored as zero (0) for incorrectly or “Don’t know” re-
sponses, while correct responses were scored one (1). A
knowledge summary score for the 12 questions asked was
calculated from the total of correct answers. Participants
with scores over 6/12 were denoted knowledgeable. Data
are presented using tables.
Ethical considerations
Ethical clearance was obtained from the Faculty of
Health Sciences Institutional Review Board (FHS-IRB) of
the University of Buea and administrative authorization
was obtained from the Regional Delegation of Public
Health for the South West Region of Cameroon. Partici-
pants had the study protocol carefully explained to them
and participation was voluntary. Written informed con-
sent was obtained from all participants. All procedures
were standard involving minimum risks. Study results
were returned to participants and incorporated into their
care by their respective providers.
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Participant characteristics
The characteristics of the 176 participants enrolled are
summarized in Table 1. The ages ranged from 17 to 42
years with a mean age of 25.7 ± 5.4 years. The predomin-
ant age group was 25–29 years representing 33% of the
general population. The majority of the participants had
completed secondary school. Thirty-six (20.7%) of the
participants were students and a greater part of the par-
ticipants 94 (54%) were employed. Amongst the married
participants, 108 (62.1%) were monogamous while 5 (2.9%)
were polygamous. Regarding gestational age and parity,
majority of the participants were in the third trimester
(64%) and multigravidas comprised the majority (58.4%)
when compared with primigravidas (31.8%) and grand
multigravidas (9.8%).
Prevalence of HBsAg
The prevalence of HBsAg in pregnancy was found to be
9.7% (95% CI, 5.7 – 15.0). The highest prevalence rateTable 1 Demographic characteristics of participants of a




< 30 139 79















First trimester 10 6.1
Second trimester 49 29.9
Third trimester 105 64.0
Parity
Primipara (1) 55 31.8
Multipara (2–4) 101 58.4
Grand multipara (>4) 17 9.8
*Some item totals may not sum up to 176 because of non-response.was observed in the age group 15–19 (20%), followed by
the age group 30–34 (13.64%). None of the assessed par-
ticipant characteristics was significantly associated with
HBsAg positivity (Table 2). Half of the participants
with HBsAg positivity were in the third trimester and
multigravidas (64.7%) constituted the majority of HBsAg
positive women. Twenty participants had right upper
quadrant tenderness among whom 4 (20%) were positive
for HBsAg. No other assessed clinical feature (hepato-
megaly, jaundice, palmar erythema, splenomegaly, finger
clubbing, abnormal urine and stool colour) suggestive of
liver disease was identified among the participants that
tested positive for HBsAg.
None of the risk factors assessed in this study was sig-
nificantly associated with HBsAg positivity. Table 3
shows the different risk factors assessed and their corre-
sponding risk ratios and p-values.
Knowledge on hepatitis B
Table 4 shows the responses to questions about knowledge
of HBV among the pregnant women who participated in
this study. As a whole, majority of the participants had
never heard of the disease called hepatitis and 80% of the
participants did not know that hepatitis B was a virus.
Only 15.9 % of the participants knew that infection withTable 2 Prevalence of HBsAg in relation to
socio-demographic and obstetrical characteristics of
pregnant women attending ANC in the Buea Health
District, Cameroon
Factor N n % RR Fisher exact
p-value
Age 0.81 1.00
< 30 139 14 10.07
≥ 30 37 3 8.11
Education 0.74 0.53
≤ Primary 34 4 11.76
>Primary 137 12 8.76
Employment 1.22 0.80
Unemployed 80 7 8.75
Employed 94 10 10.64
Marital status 1.75 0.42
Unmarried 61 4 6.56
Married 113 13 11.50
Gestational age 0.56 0.27
≤ 24 weeks 59 8 13.56
>24 weeks 105 8 7.62
Parity 0 0.38
≤ 4 156 17 10.9
>4 17 0 0
N = number of participants tested, n = positives, % = prevalence, RR = risk ratio.
Table 3 Risk factors associated with HBsAg positivity
among pregnant women in Buea Health District
Risk factor Number Positives Percentage Risk
ratio (RR)
p-value
Past surgery 0.00 0.23
No 153 17 11.11
Yes 21 0 0.00
Blood transfusion 0.00 0.61
No 161 17 10.56
Yes 12 0 0.00
Abortion 0.88 1.00
No 118 12 10.17
Yes 56 5 8.93
Scarification 0.84 0.79
No 66 7 10.61
Yes 101 9 8.91
Piercing 1.62 1.00
No 16 1 6.25
Yes 158 16 10.13
Tattoos 0.00 1.00
No 142 15 10.56
Yes 4 0 0.00
Condom use 0.00 1.00
Inconsistent 169 17 10.06
Consistent 7 0 0.00
Sex partners 0.71 1.00
≤5 159 16 10.06
>5 14 1 7.14
Past sti 0.69 0.46
No 87 10 11.49
Yes 88 7 7.45
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knowledge of HBV regarding transmission was equally
poor as < 20% of the participants had the correct know-
ledge. A hundred and forty one (80.6%) among the 176
who participated in this study did not know that an in-
fected person is capable of living without ever presenting
complaints related to the disease. Meanwhile, a smaller
2.3% had the misconception that only particular people
could be affected by the hepatitis B virus. The fact that
hepatitis B infection can cause liver cancer was affirmed
by 28 participants (15.9%) and 15.3% had the correct
knowledge about prevention of hepatitis B infection by
vaccination.
Out of the 176 participants, 137 (80%) had a know-
ledge summary score ≤ 2 while 7 (4%) had a knowledge
summary score that ranged between 3 and 5. Twenty
eight (16%) participants had a knowledge summaryscore ≥ 6 and were denoted knowledgeable for HBV.
Both inadequate and intermediate knowledge scores
were merged and termed poor knowledge so that a cut-
off value for the knowledge summary score of 6 will be
considered poor knowledge. In this case 84% of the par-
ticipants fell under the range of poor knowledge.
Among the demographic and obstetric characteristics,
only education was significantly associated with mean
KSS (p value = 0.0037).
Discussion
Screening asymptomatic people is an important instru-
ment of disease detection, prompt diagnosis and inter-
vention especially concerning a typically asymptomatic
infection such as chronic HBV infection. Given that in-
fected pregnant women stand the chance of transmitting
the HBV infection to their newborn babies, we decided
to conduct a cross-sectional study to determine what
proportion of pregnant women attending ANC in Buea
Health District have been affected by HBV. The infor-
mation gathered from this piece of work will be used by
the health care providers in the health district to make
decisions in an attempt to improve on the health stan-
dards of the district as a whole, but specifically for preg-
nant women.
In the present study, the prevalence of HBsAg among
pregnant women was found to be 9.7%. This is relatively
high in view of the fact that a vast majority of partici-
pants were asymptomatic. In comparison with studies
from other parts of the same country, the prevalence re-
ported in this study was higher than the 1.2%, 7.85%
and 7.7% reported by Thumamo &Asoquo (2004) , Kfut-
wah et al. (2012) and Fomulu et al. (2013) respectively
[11,18,19]. This difference may be because of different
socioeconomic status and the natural difference attached
to different geographic zones. Our prevalence was also
higher than the 5.4% reported in the early nineties by
Ndumbe et al. in rural pregnant women in Cameroon
[20]. We had similar results with Okoth et al. in Kenya,
who found prevalence of 9.3% [21]. Similar results were
also recorded by Makuwa et al. who found a prevalence
of 9.2% in Gabon [22]. These similarities could be ex-
plained by the fact that it is the same risk group that
was studied and also the test used was similar in
principle to the one we used in our study. We however
expected this high prevalence and this is in conformity
with the established fact that HBsAg is endemic in Afri-
can countries south of the Sahara desert of which
Cameroon is among [8]. This level of carrier state in
women of reproductive age will suggest that there is a
high risk of mother-to-infant transmission in the Buea
Health District. However, HBsAg carrier state alone in a
pregnant woman does not put the foetus at a huge risk
of being infected, instead, pregnant women who are
Table 4 Knowledge of HBV among pregnant women attending ANC in the Buea Health District, Cameroon
Knowledge question No (%) Yes (%) Don’t know (%)
Is hepatitis B a virus? 5 (2.9) 30(17.1) 140 (80)
Does hepatitis B affect the liver? 5 (2.8) 28 (15.9) 143 (81.3)
Can hepatitis B be transmitted through unsterilized needles, blades and other sharp material? 6 (3.8) 22 (12.5) 148 (84.1)
Can hepatitis B be transmitted by contaminated blood and blood products? 4 (2.3) 29 (16.5) 143 (81.3)
Is hepatitis B transmitted through unsafe sex? 7 (4.0) 24 (13.7) 144 (82.3)
Can hepatitis B be transmitted through kissing? 16(10.9) 19 (15.0) 140 (80)
Can an infected person remain without symptoms? 14 (8.0) 20 (11.4) 141 (80.6)
Can hepatitis B affect any person? 4 (2.3) 32 (18.2) 140 (79.5)
Will an infected person remain infected for life? 18(11.4) 10 (8.0) 146 (80.6)
Is a specific diet required for all infected persons? 12 (6.9) 10 (5.7) 153 (87.4)
Can hepatitis B infection cause liver cancer? 4 (2.3) 28 (15.9) 144 (81.8)
Can hepatitis B be prevented by vaccination? 6 (3.4) 27(15.34) 143 (81.3)
Note. Knowledge of HBV was assessed by assigning a point for every correct answer only. Points ranged from 0 to 12 with a mean of 1.5 ± 3.14 (median = 0, IQR =
0 to 0). Scores ≤ 2 were considered inadequate while scores within 3 and 5 were considered intermediate. Scores ≥ 6 were considered adequate and acceptable.
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infect their babies. Transmission does not only depend
of HBsAg and HBeAg status but also on anti-HBeAg
status - anti-HBeAg positivitiy tends to prevent trans-
mission [23-25]. It is estimated that transmission rates
can be as high as 12%, 25% and 70-90% respectively in
HBeAg negative/anti-HBe positive mothers, HBeAg
negative/anti-HBe negative mothers and HBeAg posi-
tive/anti-HBe negative mothers [26]. Other studies have
suggested that as many as 41% of HBsAg pregnant
women are also HBeAg positive [27]. If this were the
case in the BHD then the risk of vertical transmission in
this setting will still be high. More accurate estimates of
the risk of mother-to-infant transmission will however
require a study of HBsAg, HBeAg, anti-HBeAg levels
and HBV_DNA levels (when possible) in pregnant
women in the Buea Health district. Given the unavail-
ability of the hepatitis B immune globulin (HBIG) in
many developing countries, the use of the hepatitis B
vaccine alone is recommended and considered appropri-
ate treatment to prevent many cases of HBV during the
perinatal period – the period of highest risk of chron-
icity [28].
We did not identify significant risk factors associated
with HBsAg positivity in our study. This is contrary to
many studies carried out elsewhere as most often at least
one risk factor is identified. Blood transfusion was iden-
tified as the single risk factor for HBsAg positivity in
Mexico by Cisneros-Castolo et al. [29]. Rabiu et al.,
identified three risk factors associated with HBsAg posi-
tivity in Nigeria (early age of sexual debut, history of
multiple sexual partners and history of sexually transmit-
ted infection) [30]. In a more recent study in urban
Cameroon, only a history of contact with a jaundiced or
HBV-infected person was identified as a significantpredictor of current HBsAg positivity [11]. From these
studies, it is evident that different regions have different
risk factors associated with HBsAg positivity. Neverthe-
less, blood transfusion still remains a risk factor for
hepatitis B transmission irrespective of the region, due
to undetected donors with early acute infection, resolv-
ing infection, silent infection or infection with atypical
virus serology [31]. The main reason why we think we
did not identify risk factors associated was probably be-
cause our sample size was small and was statistically de-
termined for prevalence, not for risk factors. Also it
could be that the risk factors we assessed are not among
the risk factors associated with HBsAg positivity in Buea
Health District. Furthermore, because participants could
not possibly remember what happened to them at birth
and childhood, we could not assess two important risk
factors associated with chronic carrier status: being
borne of an HBV-positive mother and early contact in
childhood with HBV [32,33].
Apart from right upper quadrant tenderness which
was reported in one in five HBsAg-positive participants,
all other typical symptoms of hepatitis were rare. This is
not surprising as it confirms the chronic rather than
acute nature of the infection in these women.
Our result document very low levels of knowledge
about HBV infection among pregnant women who at-
tend ANC in Buea health district in general. Specifically
we noticed that more than 80% of our participants did
not know hepatitis B was a disease caused by a virus
until it was explained to them. Such low knowledge was
also observed in Seattle, Washington, by Taylor and col-
leagues [34]. Furthermore, well above 80% of our re-
spondents had no knowledge of the different methods of
transmission of HBV until it was explained to them in
terms of similarity of transmission with HIV with the
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when compared to HIV. This is similar to earlier studies
carried out by Sharma et al. [35]. The magnitude of
awareness regarding HBV transmission has generally
been observed to be quite lower than HIV though both
have similar modes of transmission, even in studies on
different risk groups like barbers and patients on dialysis.
This difference in knowledge and precisely the low level
of awareness of HBV is probably because of the lack of
formal education available about HBV as compared to
other diseases of similar modes of transmission and bur-
den. Majority of our respondents did not know that
most HBV carriers are asymptomatic and could transmit
the virus to an uninfected person through sexual inter-
course. The fact that HBV can affect any person was
known to most of our participants. Overall the poor
knowledge shown in this study is in line with findings
from Pakistan [36] and around the globe [34,37]. This
deficient knowledge warrants the need for sustained and
continuous education not only about HBV but other dis-
eases of similar magnitude and burden.
A number of limitations need to be considered in
interpreting these findings. First, only HBsAg was tested
as a marker for hepatitis B infection. Other markers exist
which if combined with HBsAg could have been more
reliable. As such this study only determined the preva-
lence of HBsAg in pregnancy in our locality. It did not
permit the calculation of the risk of mother-to-child
HBV transmission. Furthermore considering the cross-
sectional design, it is not possible to rule out or infer any
cause-effect relationship between the factors assessed and
HBsAg positivity. Studying self-reported knowledge is it-
self a limitation as one cannot rely totally on the informa-
tion provided by the participants because of recall bias
and social desirability bias. The use of a rapid test (less
sensitive when compared to ELISA and PCR tests) may
also have resulted in an underestimation of the prevalence
of HBsAg.
Conclusion
Hepatitis B virus infection is a public health problem in
Buea Health District. A 9.7% prevalence of HBsAg in an
apparently healthy population of pregnant women at-
tending ANC was recorded in this study. None of the
risk factors assessed was significant for HBsAg positivity.
Further studies using a larger sample size will be needed
to assess the risk of mother-to-child transmission of
HBV in this setting. If these high prevalence rates are
confirmed, then the public health policies to reduce the
burden of HBV, including universal immunisation, and
screening in high risk groups, need to be reinforced.
Only 16% of the pregnant women were knowledgeable
about HBV. More than 80% had misconceptions regard-
ing the methods of transmission of HBV. While keepingin view the global burden of HBV, it is important to
focus on women of child- bearing age and educate them
on HBV and its prevention.
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